These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
12. Acute toxicity and changes in quality of life during a combined radio-chemotherapy of glioblastomas with topotecan (Hycamtin). Gross MW; Altscher R; Brandtner M; Häusser-Mischlich H; Kiricuta IC; Siegmann AD; Engenhart-Cabillic R Strahlenther Onkol; 2001 Dec; 177(12):656-61. PubMed ID: 11789404 [TBL] [Abstract][Full Text] [Related]
13. GliaSite brachytherapy boost as part of initial treatment of glioblastoma multiforme: a retrospective multi-institutional pilot study. Welsh J; Sanan A; Gabayan AJ; Green SB; Lustig R; Burri S; Kwong E; Stea B Int J Radiat Oncol Biol Phys; 2007 May; 68(1):159-65. PubMed ID: 17331666 [TBL] [Abstract][Full Text] [Related]
14. Postoperative radiotherapy of glioblastoma multiforme: analysis and critical assessment of different treatment strategies and predictive factors. Piroth MD; Gagel B; Pinkawa M; Stanzel S; Asadpour B; Eble MJ Strahlenther Onkol; 2007 Dec; 183(12):695-702. PubMed ID: 18040615 [TBL] [Abstract][Full Text] [Related]
15. Randomized phase II trial comparing amrubicin with topotecan in patients with previously treated small-cell lung cancer: North Japan Lung Cancer Study Group Trial 0402. Inoue A; Sugawara S; Yamazaki K; Maemondo M; Suzuki T; Gomi K; Takanashi S; Inoue C; Inage M; Yokouchi H; Watanabe H; Tsukamoto T; Saijo Y; Ishimoto O; Hommura F; Nukiwa T J Clin Oncol; 2008 Nov; 26(33):5401-6. PubMed ID: 18854562 [TBL] [Abstract][Full Text] [Related]
16. Preservation of quality of life by preradiotherapy stereotactic radiosurgery for unresectable glioblastoma multiforme. Kong DS; Nam DH; Lee JI; Park K; Kim JH J Neurosurg; 2006 Dec; 105 Suppl():139-43. PubMed ID: 18503347 [TBL] [Abstract][Full Text] [Related]
17. A phase III study of conventional radiation therapy plus thalidomide versus conventional radiation therapy for multiple brain metastases (RTOG 0118). Knisely JP; Berkey B; Chakravarti A; Yung AW; Curran WJ; Robins HI; Movsas B; Brachman DG; Henderson RH; Mehta MP Int J Radiat Oncol Biol Phys; 2008 May; 71(1):79-86. PubMed ID: 18164847 [TBL] [Abstract][Full Text] [Related]
18. Correlation of tumor p53 and PCNA with response and survival of glioblastoma in patients treated with an ECOG protocol of pre-irradiation chemotherapy. Grunnet ML; O'Neill A; Gilbert M; Hellman R Clin Neuropathol; 2000; 19(5):230-4. PubMed ID: 11048748 [TBL] [Abstract][Full Text] [Related]
19. Results of the phase I dose-escalating study of motexafin gadolinium with standard radiotherapy in patients with glioblastoma multiforme. Ford JM; Seiferheld W; Alger JR; Wu G; Endicott TJ; Mehta M; Curran W; Phan SC Int J Radiat Oncol Biol Phys; 2007 Nov; 69(3):831-8. PubMed ID: 17560737 [TBL] [Abstract][Full Text] [Related]
20. Topotecan versus treosulfan, an alkylating agent, in patients with epithelial ovarian cancer and relapse within 12 months following 1st-line platinum/paclitaxel chemotherapy. A prospectively randomized phase III trial by the Arbeitsgemeinschaft Gynaekologische Onkologie Ovarian Cancer Study Group (AGO-OVAR). Meier W; du Bois A; Reuss A; Kuhn W; Olbricht S; Gropp M; Richter B; Lück HJ; Kimmig R; Pfisterer J Gynecol Oncol; 2009 Aug; 114(2):199-205. PubMed ID: 19446314 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]